Clinical trial
Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic…
NCT00285259 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00285259 |
|---|---|
| Title | Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) |
| Official title | A Phase 2 Clinical Trial to Evaluate the Safety, Immunogenicity, and Clinical Benefit of a CMV Immunotherapeutic Vaccine in Donors and CMV-Seropositive Recipients Undergoing Allogeneic, Matched Hematopoietic Cell Transplant (HCT) |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Collaborators | Vical Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Myelodysplastic Syndrome |
| Intervention type | Biological, Other |
| Interventions | VCL-CB01, Phosphate-buffered Saline (PBS) |
| Enrollment | 112 |
| Start date | Jan 31, 2006 |
| Primary completion | Nov 30, 2009 |
| Completion | Nov 30, 2010 |
| First posted | Feb 1, 2006 |
| Last update posted | Oct 21, 2024 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: